At-home COVID-19 test maker Cue Health (HLTH) is adding virtual appointments, treatment orders, and delivery services through its app, the company announced Monday. The idea, according to Cue ...

Covid-19 test maker Cue Health went public on Friday at a valuation of nearly $2.3 billion. Shares opened above the $16 price set the night before and closed at $20—a 25% increase in the first day of ...

SAN DIEGO, March 16, 2022 /PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH), the healthcare technology company behind the most accurate at-home COVID-19 test* in the U.S., today announced that its ...

For the third NBA season in a row, Cue Health is hoping to lead the league in assists as its go-to COVID-19 testing company. The NBA has tapped Cue to serve as its official provider of at-home and ...

Cue Health, the once high-flying San Diego biotech supplying rapid COVID-19 test kits to the NBA and Google, is laying off all employees and shutting down on Friday. Cue’s closure comes a week after ...

Last week, when many Americans were waiting in long lines and scouring drugstores for COVID-19 tests due to the spread of the omicron variant, some Googlers were casually testing daily from the ...

Fresh off the announcement that it would be slimming down its operations, with 170 manufacturing workers laid off this summer, Cue Health is back to focusing on long-term growth. Amid somewhat ...

When COVID-19 hit in March 2020, testing for the coronavirus was an absolute disaster. From manufacturing mistakes to botched rollouts to bad communication, it was incredibly difficult to track down a ...

Scaling is difficult for any company. But when your business is primed for Covid-19, growth can be as viral as the disease. That’s the case for Cue Health, a San Diego-based health care technology ...

Transitioning COVID-19 tests from emergency use authorization to the traditional pre-market pathway has long been a goal for the FDA. “Today’s authorization is the first at-home COVID-19 test granted ...